Optical imaging technique for angioplasty

Aug 10, 2010
Cross-sectional imaging of how balloon inflation in a three-layer phantom mimics a coronary artery. These images show different balloon inflation pressure: a.) partially folded balloon without pressure, b.) partially inflated balloon, c.) an inflated balloon, and d.) OCT probe rotating within a balloon (no phantom), the red dot indicates where the light beam exits the probe. Note: Imaging is performed with infrared light, but visible light is coupled in the system to ease identifying probe location. Credit: American Institute of Physics

A new optical imaging technique described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics, holds the potential to greatly improve angioplasty, a surgery commonly performed to treat patients with a partially or completely blocked coronary artery that restricts blood flow to the heart.

Angioplasty involves threading a slender, balloon-tipped tube from an artery in the groin to the trouble spot in the artery of the heart. The balloon is then inflated to compress the plaque that is blocking the artery. These balloons can also be used to deploy a stent, which is a wire-mesh tube sometimes inserted into the artery during an to keep it open and prevent reblockage.

In both cases, an optimal balloon design is critical to the success of an operation. Balloons can now be tested in a balloon deployment tester equipped with a system to monitor the outer diameter of the balloon, according to Guy Lamouche, research officer at the National Research Council of Canada.

With the goal of improving balloon deployment, the researchers investigated obtaining a more precise monitoring of balloon inflation by combining a deployment tester with an optical coherence tomography (OCT) imaging system. OCT allows imaging over a depth of a few millimeters in a tissue or material. By performing a pullback (rotation and translation) of a catheter OCT probe in a balloon, they discovered that it's possible to obtain a precise measurement of the balloon's diameter and thickness over the entire balloon.

"Combining OCT with a balloon deployment system provides an improved platform for angioplasty balloon development and can also be used in the development of next-generation minimally invasive devices for percutaneous -- through the skin -- coronary interventions," says Lamouche. "It's now possible to monitor balloon inflation within an artery phantom (model) or an excised artery to assess the efficiency of innovative balloon angioplasty or stent deployment procedures."

Explore further: Face transplants change lives, identity

More information: "Optical coherence tomography monitoring of angioplasty balloon inflation in a deployment tester" by Hamed Azarnoush, Sebastien Vergnole, Rafik Bourezak, Benoit Boulet, and Guy Lamouche, Review of Scientific Instruments. rsi.aip.org/rsinak/v81/i8/p083101_s1

Provided by American Institute of Physics

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Making emergency artery repair safer

Dec 06, 2007

Catheters outfitted with balloons, lasers, and miniature drills have made the treatment of blocked arteries virtually routine. These devices are used to clear plaque from many vessels including coronary, femoral, renal, and ...

Nanoparticles plus adult stem cells demolish plaque

Jul 19, 2010

A technique that combines nanotechnology with adult stem cells appears to destroy atherosclerotic plaque and rejuvenate the arteries, according to a study reported at the American Heart Association's Basic Cardiovascular ...

Recommended for you

Face transplants change lives, identity

17 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0